Merck Stock Quote Today

<div class='circular--portrait' style='background:#008000;color: #f8f8f8;font-size:3em;padding-top: 38px;;'>MRK</div>
Merck is trading at 78.25 as of the 15th of July 2020. This is 1.15 percent up since the beginning of the trading day. The stock's last reported lowest price was 77.36. Merck has less than a 15 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 30 days. Equity ratings for Merck Company are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 16th of April 2020 and ending today, the 15th of July 2020. Click here to learn more.
Analyze Filter   Report: 31st of July 2020

   Performance
0 100 

   Odds of Distress
15  

Merck Profile

The upcoming quarterly report is expected on the 31st of July 2020. It operates through Pharmaceutical and Animal Health segments. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug ManufacturersGeneral classification in the United States and is traded on BATS Exchange. It employs 71000 people. more on Merck
Merck Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Merck Inc SEC Filings
Merck SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameMerck Company
Older SymbolSGP
PresidentJennifer ZacharyView All
Thematic Classifications
Active investing themes Merck currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
showing 2 out of 4 themes  View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Merck Inc. The Merck consensus assessment is calculated by taking the average estimates from all of the analysts covering Merck
Piotroski F Score
Academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Merck Inc financial position. Scores of 8 and 9 are usually clasified strong value stocks whereas scores of 2 or below are considered weak value stocks.
 7 - StrongDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares2.5 B2.5 B
Fairly Down
Decreasing
Stable
Weighted Average Shares DilutedB2.6 B
Fairly Up
Decreasing
Slightly volatile
Net Cash Flow from Operations12.9 B13.4 B
Sufficiently Down
Increasing
Slightly volatile
Total Assets86 B84.4 B
Fairly Up
Decreasing
Slightly volatile
Total Liabilities61.3 B58.4 B
Sufficiently Up
Increasing
Slightly volatile
Current Assets27.2 B27.5 B
Fairly Down
Decreasing
Slightly volatile
Current Liabilities22.3 B22.2 B
Slightly Up
Increasing
Slightly volatile
Total Debt26.9 B26.3 B
Fairly Up
Increasing
Slightly volatile
Return on Average Assets0.130.118
Significantly Up
Decreasing
Very volatile
Gross Margin0.750.699
Notably Up
Increasing
Slightly volatile
Asset Turnover0.550.561
Fairly Down
Increasing
Slightly volatile
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Merck available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
Strong HoldUndervalued
Financial Strength
Merck financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Merck success along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
AA- ( Average Bond Rating ) Very Strong
  Operating Cash Flow
Merck Company (MRK) is traded on BATS Exchange in USA. It is located in 2000 Galloping Hill Road, Kenilworth, NJ 07033, United States and employs 71,000 people. Merck Company was previously known as Merck Co and was traded on BATS Exchange under the symbol SGP. Merck is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with total capitalization of 193.57 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck's market, we take the total number of its shares issued and multiply it by Merck's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Merck Inc runs under Healthcare sector within Drug Manufacturers?General industry. The entity has 2.52 B outstanding shares of which 14.56 M shares are now shorted by investors with about 1.31 days to cover shorted positions. Merck Company has about 7.44 B in cash with 12.81 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.95.
Check Merck Probability Of Bankruptcy

Ownership Allocation (%)

Merck Stock Price Odds Analysis

Odds Down 78.25HorizonTargetOdds Up 78.25
39.74%30 days
 78.25 
59.91%
Based on a normal probability distribution, the odds of Merck to move above the current price in 30 days from now is about 59.91 (This Merck Company probability density function shows the probability of Merck Stock to fall within a particular range of prices over 30 days) .

Merck Income Statement Over Time

Merck Company Income Statement is one of the three primary financial statements used for reporting Merck's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Merck Inc revenue and expense. Merck Income Statement primarily focuses on the company's revenues and expenses during a particular period. Merck Research and Development Expense is increasing as compared to previous years. The last year's value of Research and Development Expense was reported at 9.87 Billion. The current Weighted Average Shares Diluted is estimated to increase to about 3 B, while Earning Before Interest and Taxes EBIT is projected to decrease to under 10.9 B. View More Fundamentals

Merck Stock Against Markets

Did you try this?

Run ETF Directory Now

   

ETF Directory

Find actively-traded Exchange Traded Funds (ETF) from around the world
All  Next Launch Module

Merck Upcoming and Recent Events

Merck Company Earnings Announcements Dates

Upcoming Quarterly Report31st of July 2020
Next Earnings Report3rd of November 2020
Next Fiscal Quarter End30th of June 2020
Next Fiscal Year End3rd of February 2021
Last Quarter Report31st of March 2020
Last Earning Announcement30th of June 2019

Merck Corporate Filings

Merck SEC Reporting

Financial Statements and Exhibits. Other Events
View
Submission of Matters to a Vote of Security Holders
View
Unclassified Corporate Event
View

Merck Distributions to stockholders

A dividend is the distribution of a portion of Merck earnings, decided and managed by the Mercks board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Merck dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment.
12th of June 2020
13th of March 2020
13th of December 2019
13th of September 2019
14th of June 2019
14th of March 2019
14th of December 2018
14th of September 2018

Merck Corporate Directors

Thomas Glocer Independent Director
Craig Thompson Independent Director
Rochelle Lazarus Independent Director
Additionally, see Stocks Correlation. Please also try Financial Widgets module to easily integrated macroaxis content with over 30 different plug-and-play financial widgets.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page